Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Virally encoded 7TM receptors.

M M Rosenkilde1, M Waldhoer, H R Lüttichau

  • 1Laboratory for Molecular Pharmacology, Department of Pharmacology, Panum Institute, DK-2200, Denmark.

Oncogene
|April 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence that a deviation in the kynurenine pathway aggravates atherosclerotic disease in humans.

Journal of internal medicine·2020
Same author

Glucagon-like peptide 1 (GLP-1).

Molecular metabolism·2019
Same author

EBI2 in splenic and local immune responses and in autoimmunity.

Journal of leukocyte biology·2018
Same author

Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model.

Proceedings of the National Academy of Sciences of the United States of America·2017
Same author

GIP(3-30)NH<sub>2</sub> is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP-mediated insulin, glucagon, and somatostatin release.

Biochemical pharmacology·2017
Same author

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.

Nature communications·2017

Viruses use G-protein coupled receptors (GPCRs) for infection, immune evasion, and targeting. These viral GPCRs are optimized drug targets, with some linked to diseases like Kaposi's sarcoma.

Area of Science:

  • Virology
  • Molecular Biology
  • Pharmacology

Background:

  • Herpes- and poxviruses encode 7TM G-protein coupled receptors (GPCRs) derived from host chemokine systems.
  • These viral GPCRs are highly expressed in infected cells and utilized for immune evasion, cellular reprogramming, tissue targeting, or cell entry.

Purpose of the Study:

  • To investigate the role and pharmacological profiles of virally encoded 7TM GPCRs.
  • To explore the potential of these viral receptors as future drug targets.

Main Methods:

  • Pharmacological characterization of viral GPCRs.
  • Analysis of viral receptor interactions with host chemokines.
  • Investigating the signaling pathways and cellular effects of viral GPCRs, including transgenic expression studies.

Related Experiment Videos

Main Results:

  • Viral GPCRs bind various CC and CXC chemokines, with specific optimization for certain ligands like fractalkine (US28) and angiogenic chemokines (ORF74).
  • ORF74 exhibits constitutive activity, signaling through phospholipase C and MAP kinase pathways, and possesses cell-transforming properties.
  • Transgenic expression of ORF74 in lymphocytes induces lesions similar to Kaposi's sarcoma.

Conclusions:

  • Virally encoded 7TM GPCRs are crucial for viral life cycles and pathogenesis.
  • These receptors demonstrate distinct pharmacological profiles and significant biological activities.
  • Viral GPCRs represent promising targets for therapeutic intervention.